Morton B. Brown, PhD
Articles
May 23rd 2013
Medical Costs Associated With Type 2 Diabetes Complications and Comorbidities
Rui Li, PhD Dori Bilik, MBA Morton B. Brown, PhD Ping Zhang, PhD Susan L. Ettner, PhD Ronald T. Ackermann, MD Jesse C. Crosson, PhD William H. Herman, MD
A large proportion of medical costs for type 2 diabetes are attributable to complications and comorbidities, especially end stage renal disease with dialysis or kidney transplantation.
March 13th 2013
Effectiveness and Cost-Effectiveness of Diabetes Prevention Among Adherent Participants
William H. Herman, MD, MPH Sharon L. Edelstein, ScM Robert E. Ratner, MD Maria G. Montez, RN, MSHP Ronald T. Ackermann, MD, MPH Trevor J. Orchard, MD Mary A. Foulkes, PhD Ping Zhang, PhD Christopher D. Saudek, MD&dagger Morton B. Brown, PhD The Diabetes Prevention Program Research Group
Over 10 years, among adherent participants, lifestyle intervention and metformin were effective and cost-effective for diabetes prevention compared with placebo.
Latest Updated Articles
Published: August 18th 2025 | Updated: August 25th 2025
Conditional Economic Incentives Could Be Effective in Improving Adherence to Long-Acting PrEP in Transgender Adults
Published: August 19th 2025 | Updated: August 22nd 2025
Semaglutide Not Associated With Increased Risk of Eye Disorders
Published: June 6th 2025 | Updated: August 18th 2025
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
Published: June 27th 2025 | Updated: July 1st 2025
Report Reveals Mounting Burdens of Drug Shortages on US Health System
Published: February 20th 2025 | Updated: February 21st 2025
Managed Care Reflections: Insights From Richard J. Gilfillan, MD; and Donald M. Berwick, MD, MPP
Published: January 16th 2025 | Updated: January 29th 2025
FDA Proposal Aims to Reduce Smoking Addiction and SCLC Cases
